Company | Northrop Grumman Corporation |
Ticker | NOC US |
Upcoming Earnings Date | July 22, 2026 (Q2 2026) |
Last Earnings Date | April 21, 2026 (Q1 2026) |
Preparation Date | July 20, 2026 |
Sector | Aerospace & Defense |
Key Takeaway: The setup into Q2 2026 is a low bar with meaningful upside optionality — consensus has been reset lower post-Q1's guidance-hold disappointment, management guided explicitly for high single-digit sequential sales growth in Q2, and the F/A-XX downselect (expected August 2026) is an imminent binary catalyst that could re-rate the stock sharply higher.
Heading into Q2 2026, the bar for NOC is manageable: consensus revenue of ~$10.82B implies roughly 4.5% YoY growth, well within the company's full-year mid-single-digit guidance, and management's own Q2 directional guide of high single-digit sequential growth from Q1's $9.88B base points to a revenue print in the $10.7–11.0B range — suggesting consensus may be slightly conservative. The bigger swing factor is segment operating margin: consensus sits at 11.2%, above Q1's 10.8% actual, and the key question is whether the Space segment's Gen 63 XL EAC charge is fully contained (management said yes) and whether Mission Systems can sustain its 15%+ margin trajectory. On EPS, the Street at $6.81 is modestly above the post-Q1 baseline, but full-year EPS guidance of $27.40–$27.90 implies a back-half ramp that requires clean execution. The stock has underperformed the ITA defense ETF by ~18 points since Q1 earnings (NOC -14.6% vs ITA +3.4%), creating a low-expectations setup where a clean beat-and-raise could catalyze meaningful catch-up. The wildcard is the
F/A-XX downselect — with the Navy confirming an August 2026 decision between Boeing and Northrop Grumman, a NOC win on this multi-decade, potentially $100B+ program would be a transformational re-rating event; a loss would remove a key bull thesis but is likely already partially discounted given the stock's underperformance. Defense Systems' double-digit organic growth (fueled by Sentinel ramp and munitions demand) and the B-21 production rate increase agreement provide durable revenue visibility regardless of F/A-XX outcome.
Key Takeaway: Consensus is a low bar heading into Q2 2026 — management's own sequential guide implies revenue above the Street, and the margin bar (11.2% segment operating margin) is achievable given Q1's contained Space charge and Mission Systems' momentum. Segment operating margin is the bigger swing factor; a clean Space recovery and continued Mission Systems strength could drive a meaningful EPS beat.
Source: Visible Alpha Consensus and Actuals Data. All figures sourced from Visible Alpha; segment guidance from Q4 2025 and Q1 2026 earnings calls. YoY change for EPS reflects Q2 2025 included a large favorable EAC; Q2 2026 consensus reflects normalized run-rate.
KPI | Q1 2026 Actual | Q2 2025 Actual (Prior Year) | Q2 2026 Consensus Est. | YoY Change | FY2026 Guidance | Cons. vs. Guidance |
Total Sales ($B) | $9.88B | $10.35B | $10.82B | +4.5% | $43.5–$44.0B | ~In-line (midpoint $43.75B) |
Operating EPS (Diluted) | $6.14 | $8.15 | $6.81 | -16.4% | $27.40–$27.90 | Cons. FY $27.91 ≈ +0.1% above midpoint |
Segment Operating Margin (%) | 10.85% | 11.78% | 11.22% | -56 bps YoY | Low-to-mid 11% | ~In-line with guidance midpoint |
Sales — Aeronautics Systems ($B) | $3.28B | $3.11B | $3.28B | +5.5% | Mid-$13B (FY) | On track |
Sales — Defense Systems ($B) | $1.90B | $1.99B | $2.16B | +8.5% | Mid-to-high $8B (FY) | On track |
Sales — Mission Systems ($B) | $2.86B | $3.16B | $3.22B | +1.9% | High $12B (FY) | On track |
Sales — Space Systems ($B) | $2.48B | $2.65B | $2.75B | +3.8% | ~$11B (FY) | On track |
AS Operating Margin (%) | 9.29% | 10.31% | 9.38% | -93 bps YoY | Low-to-mid 9% | ~In-line |
DS Operating Margin (%) | 9.69% | 12.71% | 10.05% | -266 bps YoY | ~10% | ~In-line |
MS Operating Margin (%) | 15.13% | 13.97% | 14.68% | +71 bps YoY | High 14% | ~In-line |
Space Operating Margin (%) | 9.48% | 10.58% | 10.90% | +32 bps YoY | ~11% | ~In-line |
Free Cash Flow ($B) | -$1.82B | $0.64B | $1.14B | +78.8% | $3.1–$3.5B (FY) | On track (Q1 seasonally weak) |
Book-to-Bill Ratio (x) | 0.99x | 0.93x | 0.93x (cons.) | Flat YoY | N/A | N/A |
Backlog ($B) | $95.6B | $89.7B | $94.6B (cons.) | +5.5% | N/A | N/A |
Source: Visible Alpha Consensus and Actuals Data.
Quarter | Reported ($B) | Consensus ($B) | Surprise % | Result |
Q2 2024 | $10.22B | $10.04B | +1.8% | Beat |
Q3 2024 | $10.00B | $10.21B | -2.1% | Miss |
Q4 2024 | $10.69B | $10.98B | -2.6% | Miss |
Q1 2025 | $9.47B | $9.93B | -4.6% | Miss |
Q2 2025 | $10.35B | $10.05B | +3.0% | Beat |
Q3 2025 | $10.42B | $10.72B | -2.8% | Miss |
Q4 2025 | $11.71B | $11.63B | +0.7% | Beat |
Q1 2026 | $9.88B | $9.76B | +1.2% | Beat |
Pattern: NOC has beaten revenue consensus in 4 of the last 8 quarters, with misses concentrated in Q3 2024 through Q1 2025 (a period of Space segment headwinds and program transitions); the last two quarters show a return to beats, supporting a constructive setup.
Quarter | Reported (%) | Consensus (%) | Surprise (bps) | Result |
Q2 2024 | 10.78% | 10.89% | -11 bps | Miss |
Q3 2024 | 11.46% | 11.05% | +41 bps | Beat |
Q4 2024 | 11.16% | 11.07% | +9 bps | Beat |
Q1 2025 | 6.00% | 10.95% | -495 bps | Large Miss (EAC) |
Q2 2025 | 11.78% | 11.08% | +70 bps | Beat |
Q3 2025 | 12.25% | 11.40% | +85 bps | Beat |
Q4 2025 | 11.21% | 11.17% | +4 bps | Beat |
Q1 2026 | 10.85% | 11.06% | -21 bps | Miss |
Pattern: Excluding the Q1 2025 Sentinel EAC anomaly, NOC has beaten segment margin consensus in 5 of the last 7 comparable quarters; the Q1 2026 miss was driven by the Space Gen 63 XL charge, which management characterized as contained — setting up for a margin recovery in Q2.
Key Takeaway: Consensus is a
Key Takeaway: Consensus represents a
Key Takeaway: Full-year guidance was reaffirmed at Q1 2026 with no upward revision despite a revenue beat, but the CapEx raise to $1.85B (from $1.65B) for B-21 production acceleration was the key new disclosure; management's tone at the May 2026 Bernstein conference was constructively bullish, emphasizing accelerating growth into 2027 and a CapEx framework of ~4.5% of revenue for 2027–2028. The guidance-hold was the primary source of post-Q1 stock weakness, but the strategic narrative has strengthened.
Metric | Q4 2025 Guidance (Baseline) | Q1 2026 Guidance (Current) | Change | Management Tone |
Full-Year Sales | $43.5–$44.0B | $43.5–$44.0B | Unchanged | Reaffirmed; mid-single-digit growth |
Operating EPS | $27.40–$27.90 | $27.40–$27.90 | Unchanged | Reaffirmed; below Street consensus |
Segment Operating Margin | Low-to-mid 11% | Low-to-mid 11% | Unchanged | Confident; Space charge characterized as contained |
Free Cash Flow | $3.1–$3.5B | $3.1–$3.5B | Unchanged | Maintained despite CapEx raise |
Capital Expenditures | $1.65B | $1.85B | +$200M (B-21 production) | Proactive investment; ROIC above CoC confirmed |
Q2 2026 Sales (Directional) | Q1 up low single digits (Q1 guide) | High single-digit sequential growth | Implies ~$10.7–11.0B | Constructive; above consensus |
2027–2028 CapEx (Bernstein) | Not provided | ~4.5% of revenue | New disclosure | Framed as setup for strong 2030s returns |
Dividend | Prior rate | +7% increase (May 2026) | Raised | Tied to operating cash growth YoY |
Source: Q4 2025 and Q1 2026 NOC earnings call transcripts; May 2026 Bernstein Strategic Decisions Conference transcript.
Key Tone Shifts Since Last Earnings: At the May 2026 Bernstein conference, CEO Kathy Warden explicitly stated that the year-over-year revenue headwind from the two cancelled/lost Space programs is now fully behind the company as of Q1 2026, and expects accelerating growth with a mid-single digit or better trajectory going into 2027. She also highlighted ~150 satellites in backlog across SDA transport and tracking layers, and confirmed Defense Systems growth could reach into the 20s (from teens). The F/A-XX downselect was confirmed for August 2026 by both the CNO and Secretary Hegseth in HASC testimony, with the program funded in the FY26 budget and reconciliation bill.
Key Takeaway: Full-year guidance was reaffirmed at Q1 2026 with no upward revision despite a revenue beat, but the CapEx raise to $1.85B (from $1.65B) for B-21 production acceleration was the key new disclosure; management's tone at the May 2026 Bernstein conference was constructively bullish, emphasizing
Key Takeaway: Full-year guidance was reaffirmed at Q1 2026 with no upward revision despite a revenue beat, but the CapEx raise to $1.85B (from $1.65B) for B-21 production acceleration was the key new disclosure; management's tone at the May 2026 Bernstein conference was constructively bullish, emphasizing accelerating growth into 2027 and a CapEx framework of ~4.5% of revenue for 2027–2028.
Key Takeaway: Estimates have been revised modestly lower since Q1 2026 earnings, reflecting the guidance-hold disappointment and CapEx increase, but the gap between consensus EPS ($27.91 FY2026) and guidance midpoint ($27.65) is narrow — suggesting the Street is not pricing in a guidance raise, which creates asymmetric upside if management lifts the bar at Q2.
KPI | Pre-Q1 Earnings Estimate (Apr 20) | Post-Q1 Earnings Estimate (Apr 28) | Current Consensus (Jul 20) | Direction |
Q2 2026 Revenue | ~$10.82B (pre-Q1) | $10.82B (post-Q1 baseline) | $10.82B | → Stable |
Q2 2026 Operating EPS | ~$6.81 (pre-Q1) | $6.80 (post-Q1 baseline) | $6.81 | → Stable |
FY2026 Revenue | ~$44.0B | $44.0B | $44.0B | → Stable; in-line with guidance |
FY2026 Operating EPS | ~$28.20 (pre-Q1) | $27.91 (post-Q1 reset) | $27.91 | ↓ Reset lower post-Q1; above guidance midpoint by ~$0.26 |
FY2027 Revenue | ~$47.0B | $47.0B | $47.0B | → Stable; acceleration thesis intact |
FY2027 Operating EPS | ~$30.50 | $30.24 | $30.24 | ↓ Modest reset; CapEx headwind priced in |
Source: Visible Alpha Consensus and Actuals Data. Pre-Q1 estimates are approximate based on consensus trajectory; post-Q1 baseline from Visible Alpha as-of April 28, 2026.
Analysis: The estimate revision picture is relatively benign — the Street absorbed the Q1 guidance-hold by resetting FY2026 EPS ~$0.30 lower but has not continued to cut since. This suggests the market has largely priced in the CapEx headwind and is waiting for Q2 execution to determine whether a guidance raise is warranted. The FY2027 consensus of $30.24 implies ~8% EPS growth, which appears conservative given management's explicit commentary on accelerating top-line growth and margin tailwinds as programs transition to production.
Key Takeaway: NOC has been a significant underperformer since Q1 2026 earnings, declining ~14.6% (from $611 to $522) vs. the ITA defense ETF which is up ~3.4% over the same period — an ~18-point gap that reflects investor frustration with the guidance-hold and CapEx increase, but also creates a low-expectations setup heading into Q2 where a clean beat-and-raise could drive meaningful catch-up.
NOC vs. ITA Defense ETF — Indexed to 100 at Q1 2026 Earnings (April 21, 2026). Source: Stock Price Data.
Metric | Value | Notes |
NOC Price at Q1 Earnings (Apr 21) | $611.13 | Day of Q1 2026 earnings release |
NOC Price (Jul 17, 2026) | $521.61 | Most recent close |
NOC Return Since Q1 Earnings | -14.6% | Indexed to 85.4 (base 100) |
ITA (Defense ETF) Return Since Q1 Earnings | +3.4% | Indexed to 103.4 (base 100) |
NOC vs. ITA Spread | -18.1 pts | Significant underperformance vs. defense peers |
NOC 52-Week Low | ~$496 (Jun 29, 2026) | Trough post-earnings |
NOC 52-Week High (pre-earnings) | ~$657 (Apr 20, 2026) | Day before Q1 earnings |
Key Events Since Q1 Earnings | Dividend +7% (May 21); Bernstein Conference (May 28) | Neither event reversed the downtrend |
Source: Stock Price Data.
Stock Setup Analysis: At $521, NOC trades at approximately 18.7x FY2026 consensus EPS of $27.91 and 17.2x FY2027 consensus EPS of $30.24 — a meaningful discount to its 5-year average P/E of ~20x and to peers like LMT (~18x) and RTX (~22x). The de-rating reflects the CapEx overhang and FCF compression during the B-21 investment cycle, but the stock appears to be pricing in a sustained period of below-average returns rather than the temporary investment trough management describes. A Q2 beat with any guidance raise — particularly on EPS or FCF — could be the catalyst to close the peer gap.
Key Takeaway: NOC has been a significant underperformer since Q1 2026 earnings, declining
Key Takeaway: NOC has been a significant underperformer since Q1 2026 earnings, declining ~14.6% (from $611 to $522) vs. the ITA defense ETF which is up ~3.4% over the same period — an ~18-point gap that reflects investor frustration with the guidance-hold and CapEx increase, but also creates a
Key Takeaway: The post-Q1 period has been dominated by three themes: the B-21 production rate increase agreement and associated CapEx commitment, the F/A-XX downselect timeline confirmation (August 2026), and broad-based munitions demand acceleration driven by the Iran conflict and elevated operational tempo — all of which are net positives for NOC's long-term revenue trajectory.
Key Takeaway: Peer Q1 2026 earnings calls and May 2026 conference commentary are uniformly bullish on the defense demand environment — elevated operational tempo, munitions replenishment urgency, international demand acceleration, and missile defense growth are consistent themes across LMT, RTX, LHX, and GD that all read positively for NOC's Q2 setup. The one nuance is that RTX's preliminary Q2 results (July 9) showed strong defense performance, which is a direct positive read-through.
Relevance to NOC: RTX is the most direct read-through peer given overlapping missile defense, munitions, and space exposure. RTX raised its full-year 2026 outlook for adjusted sales and EPS following a strong Q1, citing continued defense strength. Key read-throughs:
Relevance to NOC: LMT is the closest structural peer (large defense prime, similar program mix). LMT's Q1 2026 results and conference commentary provide the most direct read-through on the defense demand environment, budget dynamics, and program execution.
Relevance to NOC: LHX overlaps with NOC in mission systems, electronic warfare, and space. LHX's Q1 2026 results and Bernstein commentary provide read-through on mission systems demand and margin dynamics.
Relevance to NOC: GD's defense segments (Combat Systems, Mission Systems) provide read-through on defense budget execution and program award timing.
Peer | Event | Key Read-Through Theme | NOC Implication | Signal |
RTX | Q1 2026 Earnings (Apr 21) | Raised FY guidance; defense strength; PAC-3 demand surge | Validates missile defense & munitions growth | Positive |
RTX | Bernstein Conference (May 29) | Continued defense strength; international demand acceleration | Validates NOC international growth thesis | Positive |
RTX | Q2 Prelim Results (Jul 9) | Strong Q2 defense performance | Direct positive read-through for NOC Q2 | Positive |
LMT | Q1 2026 Earnings (Apr 23) | Defense budget confidence; munitions demand; international acceleration | Validates NOC's demand environment and growth guide | Positive |
LMT | Bernstein Conference (May 27) | Bipartisan support for $1.15T budget; allied demand | Validates NOC's FY2026 guidance framework | Positive |
LHX | Q1 2026 Earnings (Apr 30) | Mission systems demand; EW & ISR strength; operational tempo | Validates NOC Mission Systems margin expansion | Positive |
LHX | Bernstein Conference (May 27) | Space/SDA program execution; satellite production | Context for NOC Space segment recovery | Neutral |
GD | Q1 2026 Earnings (Apr 29) | Defense budget execution; program award timing | Context for NOC book-to-bill expectations | Neutral |
BA | Q1 2026 Earnings (Apr 22) | Defense backlog record $86B; F-15EX, KC-46 ramp; PAC-3 seeker expansion | Limited direct read-through; F/A-XX competitor | Mixed |
Source: LHX Q1 2026 earnings call transcript (Apr 30, 2026); LMT Q1 2026 earnings call transcript (Apr 23, 2026); RTX Q1 2026 earnings call transcript (Apr 21, 2026); RTX Q2 2026 Preliminary Results (Jul 9, 2026); GD Q1 2026 earnings call transcript (Apr 29, 2026); BA Q1 2026 earnings call transcript (Apr 22, 2026); LHX, LMT, RTX, BA Bernstein Strategic Decisions Conference transcripts (May 27–29, 2026). Note: Only commentary about Q2 2026 current quarter trends or post-Q1 2026 forward-looking commentary is included; prior-quarter result discussions are excluded.
Key Takeaway: Insider activity since Q1 2026 earnings is minimal and not directionally meaningful — the only transaction on record is a small planned sale by a Director under a 10b5-1 plan, which is routine and carries no informational signal about management's view of Q2 prospects.
Insider Name | Role | Transaction Date | Type | Shares | Security | 10b5-1 Plan? | Shares Owned After |
Welsh, Mark A III | Director | May 4, 2026 | Sale (Disposition) | 95 shares | Common Stock | Yes (pre-planned) | 4,121 shares |
Source: Insider Transaction Data (Form 4 Filing — Welsh Mark A III, NOC, filed May 5, 2026).
Analysis: The sole insider transaction since Q1 2026 earnings is a small 95-share sale by Director Mark Welsh under a pre-established 10b5-1 trading plan. 10b5-1 sales are scheduled in advance and are not indicative of the insider's current view on the stock. The absence of any open-market purchases or non-plan sales by senior management (CEO, CFO, or other executives) is neutral — it neither confirms nor contradicts the bull thesis. The lack of insider buying at current depressed levels (~$521, down ~14.6% from pre-earnings highs) is worth noting but is not unusual given the pending F/A-XX decision and associated quiet period considerations.
Key Takeaway: The primary downside risks are another Space segment EAC charge, a further guidance-hold without a raise, and an F/A-XX loss; the primary upside risks are a guidance raise, F/A-XX win, and accelerating international awards.
Risk / Opportunity | Direction | Description | Probability |
Space Segment EAC Charge | Downside | Another unfavorable EAC (beyond Gen 63 XL) would pressure margins and EPS; management said Q1 charge is contained but Space has a history of surprises | Low-Medium |
Guidance Hold (No Raise) | Downside | A second consecutive guidance reaffirmation without a raise would disappoint investors who expect the back-half ramp to justify an upward revision | Medium |
F/A-XX Loss (August 2026) | Downside | A Boeing win would remove a key bull thesis; however, the stock's underperformance may already partially discount this risk | Medium |
CapEx Overrun / FCF Miss | Downside | B-21 production investment could require additional CapEx beyond the $1.85B guide, compressing FCF below the $3.1–3.5B range | Low-Medium |
F/A-XX Win (August 2026) | Upside | A NOC win on the multi-decade, $100B+ F/A-XX program would be a transformational re-rating event; could add $50–$100+ to the stock | Medium |
Guidance Raise at Q2 | Upside | A revenue or EPS guidance raise would signal management confidence in the back-half ramp and could close the peer valuation gap | Medium |
International Awards Acceleration | Upside | Accelerating international awards (IBCS, E-2D, munitions) could drive book-to-bill above 1.0x and boost backlog above consensus $94.6B | Medium-High |
Defense Budget / CR Risk | Downside | A continuing resolution or budget impasse could delay program awards and slow revenue ramp; bipartisan support for $1.15T budget reduces but does not eliminate this risk | Low |
— End of NOC Q2 2026 Earnings Preview —